Cancer Communications
indexed by SCI
BMC

Research highlight
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
Gunnar Folprecht
Medical Department I, University Hospital Carl Gustav Carus, 01307, Dresden, Germany
[Abstract] N/A
Cancer Communications   Epub date: 11/14/2019   doi:10.1186/s40880-019-0417-1
[PDF Full-text]

[ Html full-text] (BioMed Central)

[ PubMed]

Cite this article

Gunnar Folprecht. Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer. Cancer Commun (Lond). 2019, 39:74. doi:10.1186/s40880-019-0417-1


Export citations

EndNote

CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China